Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

PaperCitations, authors & open-access status

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 17 citations, 2021 year and closed oa status.

17
Citations
2021
Year
closed
OA Status

Related on ScholarIQ

Ben Johnson
Author
Bone health and osteoporosis research
Topic
Bone health and osteoporosis research
Topic
Bone health and treatments
Topic
Bone Metabolism and Diseases
Topic
470M+ articles · free account